search icon

    Market Snapshot

    • S&P Futures

      3,914.75

    • Dow Futures

      31,478

    • Nasdaq Futures

      12,132.75

    blog search icon

    Gritstone bio, Inc.

    (NASDAQ:GRTS)

    $2.66

    $0.13

    5.14%

    Gritstone bio, Inc. Chart

    GRTS Stock Price Today

    Gritstone bio, Inc. (GRTS) stock rallied over 5.14% intraday to trade at $2.66 a share on NASDAQ. The stock opened with a gain of 14.16% at $2.53 and touched an intraday high of $2.66, rising 5.14% against the last close of $2.53. The stock went to a low of $2.44 during the session.

    Stock Snapshot

    $2.53

    Prev. Close

    185.83 Million

    Market Cap

    $2.44

    Day Low

    $2.53

    Open

    86.28 Million

    Number of Shares

    $2.66

    Day High

    -

    P/E ratio

    -1.58

    EPS (TTM)

    2.77

    Cash Flow per Share

    5.94

    Free Float in %

    3.24

    Book Value

    1,043,836

    Volume

    Gritstone bio, Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-06-23$2.53$2.66$2.44$2.661,044,400
    2022-06-22$2.33$2.64$2.29$2.531,396,500
    2022-06-21$2.29$2.42$2.25$2.381,040,500
    2022-06-17$2.11$2.33$2.09$2.221,729,400
    2022-06-16$2.11$2.17$2.02$2.131,212,700
    2022-06-15$2.14$2.24$2.09$2.19854,500
    2022-06-14$2.15$2.15$2.04$2.1877,800
    2022-06-13$2.22$2.22$2.03$2.081,035,300
    2022-06-10$2.25$2.33$2.19$2.251,548,000
    2022-06-09$2.31$2.35$2.24$2.261,821,700

    Contact Details

    5959 Horton Street
    Suite 300
    EmeryVille, CA 94608
    United States

    Webiste:GRTS

    510 871 6100

    Company Information

    Employees-

    Beta0.6

    Sales or Revenue48.21 Million

    5Y Sales Change-

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder and microsatellite stable, and colorectal cancers. The company is also developing SLATE, an off-the-shelf immunotherapy candidate for the treatment of common solid tumors comprising metastatic non-small cell lung cancer, colorectal cancer, pancreatic cancer, and shared neoantigen-positive tumors. In addition, it develops CORAL, a SARS-CoV-2 vaccine platform designed to deliver spike and additional SARS-CoV-2 T cell epitopes for protection and broader immunity against SARS-CoV-2 variants; and a therapeutic vaccine candidate designed to treat and cure human immunodeficiency virus (HIV) infection. It has a strategic collaboration with bluebird bio, Inc.; collaboration agreement with Gilead Sciences, Inc.; and license agreement with Genevant Sciences GmbH. The company was formerly known as Gritstone Oncology, Inc. and changed its name to Gritstone bio, Inc. in May 2021. Gritstone bio, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.

    Frequently Asked Questions

    icon

    What is the current Gritstone bio, Inc. (GRTS) stock price?

    Gritstone bio, Inc. (NASDAQ: GRTS) stock price is $2.66 as of the last check on Thursday, June 23. During the trading session, GRTS stock reached the peak price of $2.66 while $2.44 was the lowest point it dropped to.

    icon

    GRTS's industry and sector of operation?

    The NASDAQ listed GRTS is part of Biotechnology industry that operates in the broader Health Care sector. Gritstone bio, Inc. , a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases.

    icon

    Who are the executives of GRTS?

    Mr. Erin E. Jones M.S.
    Chief Operating Officer
    Dr. Karin Jooss
    Head of R&D
    Mr. Alan C. Mendelson J.D.
    Sec.
    Dr. Andrew R. Allen BCh, BM, M.D., MA, MRCP, Ph.D.
    Co-Founder, Pres, CEO & Director

    icon

    What is the GRTS stock price today?

    GRTS stock traded closed the last session at $2.66, which is $0.13 or 5.14% lower than its previous close of $2.53. GRTS's current trading price is 55.56% lower than its 52-week high of $14.42 where as its distance from 52-week low of 1.71% is -81.55%.

    icon

    How many employees does GRTS have?

    Number of GRTS employees currently stands at -. GRTS operates from 5959 Horton Street, Suite 300, EmeryVille, CA 94608, United States.

    icon

    Link for GRTS official website?

    Official Webiste of $GRTS is: https://gritstonebio.com

    icon

    How do I contact GRTS?

    GRTS could be contacted at GRTS operates from 5959 Horton Street, Suite 300, EmeryVille, CA 94608, United States, or at phone #510 871 6100 and can also be accessed through its website.

    icon

    How many shares of GRTS are traded daily?

    GRTS stock volume for the day was 1,043,836 shares while in the previous session number of GRTS shares traded was 1,044,400 . The average number of GRTS shares traded daily for last 3 months was 1.2 Million.

    icon

    How much did GRTS change today?

    The percentage change in GRTS stock occurred in the recent session was 5.14% while the dollar amount for the price change in GRTS stock was $0.13.

    icon

    What price range GRTS stock been trading in?

    In the recent session, the day high for GRTS stock was $2.66 while the low for GRTS stock touched on the day was $2.44.

    icon

    What is the market cap of GRTS currently?

    The market value of GRTS currently stands at 185.83 Million with its latest stock price at $2.66 and 86.28 Million of its shares outstanding.